Skip to content

13F-HR filed by Yu Fan

Yu Fan filed this 13F-HR for the quarter ended 2025-03-31, filed 2025-05-15, with 9 holding rows worth $97,313,288.

Accession
0000950123-25-005584
Filed
2025-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2025

A combination report, 9 entries on the cover page, a total value of $97,313,288 stated on the cover page (in dollars after the unit check, H1), rows summing to $97,313,288 with VALUE read as dollars as filed, 13F file number 028-20833. The quarter's positions are built on this report. The resolved quarter.

Other managers

  • reports for this filerABG Innovation Capital Partners III GP Limited 028-20837
  • reports for this filerAlly Bridge Group (NY) LLC 028-20834

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
KESTRA MED TECHNOLOGIES LTDG52441105SHS2,282,519$56,880,373dollars as filed
CERIBELL INC15678C102COMMON STOCK1,222,202$23,478,500dollars as filed
ALUMIS INC022307102COM789,618$4,848,255dollars as filed
CG ONCOLOGY INC156944100COMMON STOCK163,456$4,003,037dollars as filed
CARGO THERAPEUTICS INC COM14179K101Stock912,000$3,713,664dollars as filed
WHITEHAWK THERAPEUTICS INC00032Q104CMN2,070,000$3,684,600dollars as filed
CASTLE BIOSCIENCES INC14843C105COMMON STOCK22,503$450,510dollars as filed
SAGIMET BIOSCIENCES INC A786700104COMMON STOCK57,190$186,439dollars as filed
PYXIS ONCOLOGY INC COMMON STOCK747324101Stock69,303$67,910dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-25-005584this filing2025-05-15acceptance time not in the bulk data set